[ad_1]
Las Vegas Raiders attacking player Jimmy Garoppolo will miss the first two games of next season for violating the NFL performance-enhancing drug policy, CBS Sports directs NFL expert Jonathan Jones Has confirmed.
ESPN reports that Garoppolo’s violation was related to “using a prescription medication without having a valid Therapeutic Use Authorization.” Garoppolo will be suspended no matter what team he is on, but he is not expected to return to the Raiders.
The Raiders are expected to release Garoppolo before the fifth day of the new league year in mid-March. According to Adam Schefter, so they can avoid paying his $11.25 million roster bonus. According to Spotrac, Garoppolo’s fully guaranteed $11.25 million salary for 2024 will likely be voided due to the suspension. That would mean that upon Garoppolo’s release, the Raiders would have a $17 million dead cap hit and free up $10 million in cap space for 2024.
Given his experience, Garoppolo could become a sought-after backup upon his release, but it seems unlikely he will land anywhere as a starting quarterback.
Garoppolo signed a three-year, $72.5 million contract with Las Vegas last offseason after spending the first nine years of his career in New England (three-plus seasons) and San Francisco (five-plus seasons). His signing was initially delayed because he needed surgery for a foot injury, but he eventually returned to training camp.
Garoppolo managed to start just six games for the Raiders, going 3-3 while completing 65.1% of his passes for an average of 7.1 yards per attempt, with seven touchdowns against nine interceptions. Injuries and ineffectiveness led to him being benched in favor of the fourth-round rookie. Aidan O’Connell.
As for the Raiders’ QB situation, they will be in the market for one this offseason, and could even trade him up to select one in the 2024 NFL Draft. via NFL media.
[ad_2]
Source link